ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Regeneron Pharmaceuticals
The Associate Director will own end‑to‑end CDx programs, translating biomarker insights into validated diagnostic assays that support drug development decisions. The role works across translational science, clinical development, regulatory affairs, and external IVD partners to align diagnostic milestones with therapeutic timelines.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
MarketBeatQuadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
The Globe and MailIn 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Simply Wall StWill Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
21% below the average for this role
Seeking AlphaRegeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Director, Biomarker Development, Strategy, and Operations
Zenas BioPharma
Translational Biomarker and CDx Leader
Pierre Fabre Group
Director, Regulatory Affairs Companion Diagnostics
Revolution Medicines
Senior Manager, Biomarker Development
Tango Therapeutics
Director, CDx Regulatory Consultant
Precision Medicine Group
Director, CDx & Clinical Platform Development
1000 Genentech, Inc.